Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients

BioMetals

Volumn 21, Issue 3, 2008, Pages 367-372

  Capo, Concetta R ^a   Arciello, Mario ^a   Squitti, Rosanna ^b   Cassetta, Emanuele ^b   Rossini, Paolo Maria ^b   Calabrese, Lilia ^c   Rossi, Luisa ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Ceruloplasmin; Copper; Serum

Indexed keywords

CERULOPLASMIN; COPPER;

AGED; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; COPPER METABOLISM; ENZYME ACTIVITY; FEMALE; HOMEOSTASIS; HUMAN; MALE; NERVE DEGENERATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; STAINING; WESTERN BLOTTING;

AGED; ALZHEIMER DISEASE; CERULOPLASMIN; FEMALE; HOLOENZYMES; HUMANS; MALE;

EID: 42549102390     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-007-9125-4     Document Type: Article

References (28)

1. Aldred AR, Grimes A, Schreiber G, Mercer JF (1987) Rat ceruloplasmin. Molecular cloning and gene expression in liver, choroid plexus, yolk sac, placenta, and testis. J Biol Chem 262:2875-2878
2. Aldred AR, Brack CM, Schreiber G (1995) The cerebral expression of plasma protein genes in different species. Comp Biochem Physiol B Biochem Mol Biol 111:1-15
3. Bielli P, Calabrese L (2002) Structure to function relationships in ceruloplasmin: a 'moonlighting' protein. Cell Mol Life Sci 59:1413-1427
4. Hellman NE, Gitlin JD (2002) Ceruloplasmin metabolism and function. Ann Rev Nutr 22:439-458
5. Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, de Jong GJ, Gitlin JD (2002) Mechanisms of copper incorporation into human ceruloplasmin. J Biol Chem 277:46632-46638
6. Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Kruger R, Becker G, Riess O, Berg D (2005) Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J 19:1851-1853
7. Iwase T, Nishimura M, Sugimura H, Igarashi H, Ozawa F, Shinmura K, Suzuki M, Tanaka M, Kino I (1996) Localization of Menkes gene expression in the mouse brain; its association with neurological manifestations in Menkes model mice. Acta Neuropathol (Berl) 91:482-488
8. Jacobsson J, Jonsson PA, Andersen PM, Forsgren L, Marklund SL (2001) Superoxide dismutase in CSF from amyotrophic lateral sclerosis patients with and without CuZn-superoxide dismutase mutations. Brain 124:1461-1466
9. Klomp LW, Farhangrazi ZS, Dugan LL, Gitlin JD (1996) Ceruloplasmin gene expression in the murine central nervous system. J Clin Invest 98:207-215
10. Linder MC, Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S-811S
11. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
12. Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX (2005) Metals and amyloid-beta in Alzheimer's disease. Int J Exp Pathol 86:147-159
13. Melo TM, Larsen C, White LR, Aasly J, Sjobakk TE, Flaten TP, Sonnewald U, Syversen T (2003) Manganese, copper, and zinc in cerebrospinal fluid from patients with multiple sclerosis. Biol Trace Elem Res 93:1-8
14. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD (1998) CSF abnormalities in patients with aceruloplasminemia. Neurology 51:1188-1190
15. Miyajima H, Kono S, Takahashi Y, Sugimoto M (2002) Increased lipid peroxidation and mitochondrial dysfunction in aceruloplasminemia brains. Blood Cells Mol Dis 29:433-438
16. Molina JA, Jimenez-Jimenez FJ, AguilarMeseguer MVI, Mateos-Vega CJ, Gonzalez-Munoz MJ, de Bustos F, Porta J, Orti-Pareja M, Zurdo M, Barrios E, Martinez-Para MC (1998) Cerebrospinal fluid levels of transition metals in patients with Alzheimer's disease. J Neural Transm 105:479-488
17. Musci G, Bonaccorsi di Patti MC, Fagiolo U, Calabrese L (1993) Age-related changes in human ceruloplasmin. Evidence for oxidative modifications. J Biol Chem 268:13388-13395
18. Pajonk FG, Kessler H, Supprian T, Hamzei P, Bach D, Schweickhardt J, Herrmann W, Obeid R, Simons A, Falkai P, Multhaup G, Bayer TA (2005) Cognitive decline correlates with low plasma concentrations of copper in patients with mild to moderate Alzheimer's disease. J Alzheimers Dis 8:23-27
19. Qian Y, Tiffany-Castiglioni E, Welsh J, Harris ED (1998) Copper efflux from murine microvascular cells requires expression of the Menkes disease Cu-ATPase. J Nutr 128:1276-1282
20. Sato M, Gitlin JD (1991) Mechanisms of copper incorporation during the biosynthesis of human ceruloplasmin. J Biol Chem 266:5128-5134
21. Schosinsky KH, Lehmann HP, Beeler MF (1974) Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20:1556-1563
22. Serot JM, Bene MC, Faure GC (2003) Choroid plexus, aging of the brain, and Alzheimer's disease. Front Biosci 8: s515-521
23. Shim H, Harris ZL (2003) Genetic defects in copper metabolism. J Nutr 133:1527S-1531S
24. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini PM (2006) Excess of non ceruloplasmin serum copper in AD correlates with MMSE, CSF β-AMYLOID and h-TAU. Neurology 67:76-82
25. Terada K, Nakako T, Yang XL, Iida M, Aiba N, Minamiya Y, Nakai M, Sakaki T, Miura N, Sugiyama T (1998) Restoration of holoceruloplasmin synthesis in LEC rat after infusion of recombinant adenovirus bearing WND cDNA. J Biol Chem 273:1815-1820
26. Walshe JM (2003) Wilson's disease: the importance of measuring serum ceruloplasmin non-immunologically. Ann Clin Biochem 40:115-121
27. Wand GS, May C, May V, Whitehouse PJ, Rapoport SJ, Eipper BA (1987) Alzheimer's disease: low levels of peptide alpha-amidation activity in brain and CSF. Neurology 37:1057-1061
28. Yoshida K, Furihata K, Takeda S, Nakamura A, Yamamoto K, Morita H, Hiyamuta S, Ikeda S, Shimizu N, Yanagisawa N (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans. Nat Genet 9:267-272